| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.37 MB | Adobe PDF | |||
| 1.74 KB | Text |
Authors
Advisor(s)
Abstract(s)
Warfarin has been one of the most used oral anticoagulant drugs over the last 60 years in the prevention of thromboembolic disease complications.
Description
Keywords
Pedagogical Context
Citation
Ferreira, J., & Santos, M. (2013, setembro). Influence of CYP2C9 genetic polymorphisms on the warfarin anticoagulant [Comunicação]. Second ESTSP Conference «Pharmacogenomics: from Cell to Clinic, Lisboa.